Day: August 9, 2023

Viemed Healthcare Announces Second Quarter 2023 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

LAFAYETTE, La., Aug. 09, 2023 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and six months ended June 30, 2023. Operational highlights (all dollar amounts are USD): Net revenues attributable to the Company’s core business for the quarter ended June 30, 2023 reached a new Company record of $43.3 million, representing an increase of $10.2 million, or 31%, over core net revenues reported for the comparable quarter ended June 30, 2022. Net revenues for the quarter ended June 30, 2023 included approximately $2.5 million of revenues related to the HMP acquisition and were up approximately 9% over the quarter ended...

Continue reading

Nephros Announces Results for Quarter Ended June 30, 2023

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Second-Quarter Net Revenue of $3.5 Million, a 24% Increase Over 2022;Year-to-Date Revenue Increases 45%; Maintains Positive Cash Flow Results SOUTH ORANGE, NJ, Aug. 09, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2023. Financial Highlights* Net revenue from continuing operations of $3.5 million, an increase of 24% Net loss from continuing operations of $0.4 million, compared to $0.7 million Adjusted EBITDA from continuing operations of ($0.2 million), compared to ($0.4 million) *Stated performance is relative to same period prior year (second quarter of 2022) “Last quarter, Nephros achieved two significant milestones: positive...

Continue reading

Alta Equipment Group Announces Second Quarter 2023 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Second Quarter Financial Highlights: (comparisons are year over year) Total revenues increased 15.2% year over year to $468.4 million Construction and Material Handling revenues of $281.5 million and $169.1 million, respectively Newly introduced reporting segment, Master Distribution, with revenues of $21.4 million Product Support revenues increased 19.1% year over year with Parts Sales increasing to $71.3 million and Service Revenues increasing to $59.7 million New and Used Equipment sales grew 17.2% to $254.6 million Net income of $1.7 million available to common stockholders compared to $5.4 million in 2022 Basic and diluted net income per share of $0.05 for 2023 compared to $0.17 in 2022 Adjusted basic and diluted net income per share* of $0.19 for 2023 compared to $0.26 for 2022 Adjusted EBITDA* grew 20.5% to $49.9 million, compared...

Continue reading

PaxMedica, Inc. Announces Second Quarter 2023 Financial Results and Business Update

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

TARRYTOWN, NY, Aug. 09, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms, today provided a business update and reported financial results for the second quarter 2023, ended June 30, 2023. Recent Highlights Announced positive top line results from the PAX-101 (intravenous suramin) Phase 3 African Sleeping Sickness Study, PAX-HAT-301, paving the way for an expected NDA filing in 2024 Granted Exclusive Pharmacy Distribution Rights for PAX-101 to Vox Nova, LLC, the first purpose-built limited distribution specialty pharmacy benefit manager for people with autism spectrum disorder (“ASD”) and their families Submitted PAX-101...

Continue reading

Montauk Renewables Announces Second Quarter 2023 Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

PITTSBURGH, Aug. 09, 2023 (GLOBE NEWSWIRE) — Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery, and conversion of biogas into renewable natural gas (“RNG”), today announced financial results for the second quarter ended June 30, 2023. Second Quarter Financial Highlights: Revenues of $53.3 million, decreased 21.5% as compared to the second quarter of 2022 Net Income of $1.0 million, decreased 94.8% as compared to the second quarter of 2022 Non-GAAP Adjusted EBITDA of $19.2 million, decreased 30.4% as compared to the second quarter of 2022 RNG production of 1.4 million MMBtu, decreased 2.6% as compared to the second quarter of 2022 On June 21, 2023, the Environmental Protection Agency announced final rules for the Renewable Fuel Standard for...

Continue reading

HF Foods Reports Second Quarter 2023 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

First Half Record Net Revenue Focus is to Reduce Cost Structure and Transform Operations LAS VEGAS, Aug. 09, 2023 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG), a leading food distributor to Asian restaurants across the United States (“HF Foods”, “HF Group” or the “Company”), reported financial results for the second quarter and six months ended June 30, 2023. Second Quarter 2023 Financial Results Net revenue decreased 2.4% to $292.3 million compared to $299.6 million in the prior year. Gross profit decreased 3.6% to $50.7 million, or 17.3% gross profit margin compared to $52.6 million, or 17.5% gross profit margin in the prior year. Net (loss) income decreased to a net loss of $1.6 million compared to net income of $4.5 million in the prior year. Adjusted EBITDA decreased 50.1% to $6.9 million compared to $13.9 million...

Continue reading

Context Therapeutics Reports Second Quarter 2023 Operating and Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Company expects its cash and cash equivalents will continue to fund operations into late 2024 Cash and cash equivalents of $25.1 million as of June 30, 2023 CTIM-76 IND filing on track for Q1 2024 PHILADELPHIA, Aug. 09, 2023 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced its financial results for the second quarter ended June 30, 2023, and reported on recent and upcoming business highlights. “During the second quarter of this year, Context continued development of our preclinical asset CTIM-76, a Claudin 6 (“CLDN6”) x CD3 bispecific antibody. An immunotherapy designed to activate and direct a patient’s own immune cells, CTIM-76 shows a high degree of specificity in preclinical studies and the potential...

Continue reading

Seneca Foods Reports Sales and Earnings for the Three Months Ended July 1, 2023

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

FAIRPORT, N.Y., Aug. 09, 2023 (GLOBE NEWSWIRE) — Seneca Foods Corporation (NASDAQ: SENEA, SENEB) today announced financial results for the three months ended July 1, 2023. Executive Summary (vs. year-ago, year-to-date results): Net sales for the first quarter of fiscal 2024 totaled $298.7 million compared to $265.2 for the first quarter of fiscal 2023. The year-over-year increase of $33.5 million was mainly due to higher selling prices partially offset by lower sales volumes. Gross margin as a percentage of net sales is 18.5% for the three months ended July 1, 2023 as compared to 8.6% for the three months ended July 2, 2022. “The Company had a strong first quarter of fiscal 2024, with sales and FIFO EBITDA increasing compared to first quarter of fiscal 2023,” stated Paul Palmby, President and Chief Executive Officer of Seneca...

Continue reading

Profire Energy Reports Financial Results for Second Quarter 2023

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Company Reports Best Six-Month Revenue and Net Income in Company History LINDON, Utah, Aug. 09, 2023 (GLOBE NEWSWIRE) — Profire Energy, Inc. (NASDAQ: PFIE), a technology company (the “Company”) that provides solutions which enhance the efficiency, safety, and reliability of industrial combustion appliances, today reported financial results for its second quarter ending June 30, 2023. A conference call will be held on Thursday, August 10, 2023, at 8:30 a.m. ET to discuss the results. Second Quarter Summary (comparisons to prior-year quarter) Revenue of $14.4 million, a 50% increase Gross profit of $7.4 million, a 68% increase Gross margin of 51.3%, a 560 basis point increase Net income of $2.9 million, or $0.06 per diluted share, versus $284,829 and $0.01 Generated EBITDA of $3.7 million, versus $587,024 Cash and investments...

Continue reading

Karat Packaging Reports 2023 Second Quarter Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

— Sustained Strong Margin Expansion — CHINO, Calif., Aug. 09, 2023 (GLOBE NEWSWIRE) — Karat Packaging Inc. (Nasdaq: KRT) (“Karat” or the “Company”), a specialty distributor and manufacturer of environmentally friendly, disposable foodservice products and related items, today announced financial results for its quarter ended June 30, 2023. Second Quarter 2023 Highlights Quarterly net sales of $108.7 million, down 5.3 percent from the prior-year quarter. Gross profit of $41.9 million, up 23.3 percent from the prior-year quarter. Gross margin of 38.5 percent versus 29.6 percent in the prior-year quarter. Net income of $10.7 million, up 48.3 percent from the prior-year quarter. Net income margin of 9.8 percent versus 6.3 percent in the prior-year quarter. Adjusted EBITDA of $21.1 million, up $9.3 million, or 78.6 percent...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.